Skip to content

Evaluation of Different Disease Control Indices in Children With Asthma and Rhinitis

Evaluation of Different Disease Control Indices in Children With Asthma and Rhinitis

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00952835
Enrollment
1000
Registered
2009-08-06
Start date
2009-07-31
Completion date
2014-12-31
Last updated
2013-06-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma, Rhinitis

Keywords

Asthma, rhinitis, EIB, Exhaled Nitric oxide, lung function, vitamin d

Brief summary

In this study will be consecutive enrolled children with asthma (classified according to GINA guidelines) and rhinitis (classified by ARIA guidelines); the investigators will research clinical personal and parental history regarding allergic diseases, exposition to passive smoking and interpretate hematochemical parameters markers of atopy. Skin Prick Tests will be performed. In this study the investigators will evaluate lung function parameters (spirometry with bronchial reversibility test and exercise induced bronchoconstriction, oscillometry, respiratory plethysmography, etc.), airway inflammatory indices such as exhaled nitric oxide at different flows, exhaled and nasal temperature, nasal cytology. The aim of the study will be to evaluate possible correlation between these different parameters and clinical status of the patients.

Detailed description

Each patients will be evaluated by spirometry and then he will undergo exercise challenge in order to evaluate exercise-induced bronchoconstriction as a marker of asthma control. The test of the challenge will be correlate with childhood Asthma control test score,levels of control (GINA classification)and the different markers of airway inflammation and atopy.

Interventions

regular treatment

Sponsors

Azienda Ospedaliera Universitaria Policlinico
CollaboratorOTHER
Universita di Verona
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
5 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patient with asthma and rhinitis

Exclusion criteria

* age \<5 years * chronic respiratory diseases

Design outcomes

Primary

MeasureTime frame
Evaluation of Different Disease Control Indices in Children With Asthma and RhinitisEvaluation of Different Disease Control Indices in Children With Asthma and Rhinitis

Countries

Italy

Contacts

Primary ContactAttilio Boner, MD
attilio.boner@univr.it--390458124615

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 25, 2026